Health
CanSino to start Phase III trial of COVID-19 vaccine in Saudi – Marketscreener.com
Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
… | August 9, 2020
DUBAI, Aug 9 (Reuters) – Saudi Arabia will soon begin Phase
III clinical trials on around 5,000 people for a COVID-19
vaccine developed by China’s CanSino Biologics Inc, a
Saudi health ministry spokesman said on Sunday.
Last month, CanSino’s co-founder said the company was in
talks with Russia, Brazil, Chile and Saudi Arabia to launch a
Phase III trial of the vaccine candidate, Ad5-nCOV.
The vaccine uses a harmless cold virus known as adenovirus
type-5 (Ad5) to carry genetic material fro…
-
Noosa News8 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General14 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News16 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family
-
General10 hours agoMan dies at shopping centre car park at Charlestown following reports of assault